ISPOR EU 2021
Check Out Our Accepted Posters
Poster 1: Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States
The objective of this study was to evaluate the impact of COVID-19 on influenza vaccines sales.
Authors:
- Armel Ngami (Syneos Health), Thomas Christie (InfoAccess), G. Ménin (Sanofi Pasteur), Florent Guelfucci (Syneos Health), Florence Bianic (Syneos Health), Pierre Net (Syneos Health)
Poster 2: Public Health and Economic Impact of Influenza Immunization by Pharmacists: A Systematic Literature Review and Analysis of the French Experience
We conducted a systematic literature review (SLR) to assess the public health and economic impact of influenza immunization by pharmacists to inform what could be the expected outcomes in France.
Authors:
- Darina Proshenska (Syneos Health), Géraldine Ménin (Sanofi Pasteur) , Florence Bianic (Syneos Health) , Pierre Net (Syneos Health)
Poster 3: Economic Impact and Public Health Benefit of Influenza Immunization by Pharmacists in France
We evaluated the public health and economic impact of influenza vaccination by pharmacists using a budget impact model.
Authors:
- Mafalda Costa (Syneos Health), Géraldine Ménin (Sanofi Pasteur), FP. Alvarez (Sanofi Pasteur), Florence Bianic (Syneos Health), Pierre Net (Syneos Health)
Poster 4: Impact of the COVID-19 Pandemic on Influenza Vaccination Policies
The objective of this study was to evaluate the impact of the COVID-19 pandemic on influenza vaccination policies.
Authors:
- Pierre Net (Syneos Health) , Javier de Renteria (Syneos Health), Florence Bianic (Syneos Health)
Poster 5: Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital
This study aimed at quantifying the impact of COVID-19 and lockdowns on surgical activity in a French university teaching hospital.
Authors:
- Léo Cazin (Ambroise Paré Hospital), Armel Ngami (Syneos Health), Louise Parenne (Ambroise Paré Hospital)
Poster 6: Impact of COVID-19 on Influenza Vaccine Coverage Rate during the 2020/2021 Season
The objective of this study was to assess the evolution of influenza vaccine coverage rate (VCR) under the COVID-19 pandemic.
Authors:
- Armel Ngami (Syneos Health), Florent Guelfucci (Syneos Health), Florence Bianic (Syneos Health), Pierre Net (Syneos Health)
Poster 7: Healthcare Resource Utilization (HRU) Survey to Inform HRU DATA Collection Alongside the Double-Blinded Trilynx Study Evaluating Xevinapant in Combination with Chemoradiotherapy Versus PlaceboPLUS Chemoradiotherapy in Patients with Previously Untreated Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)
The aim of the survey was to inform HRU data collection in the Phase 3 trial as limited HRU data are available from the literature in SCCHN.
Authors:
- Erwin De Cock (Syneos Health) & Carla Vossen (Syneos Health)
Poster 8: Workflow Mapping of the Paediatric Hexavalent Immunisation Process in the United Kingdom (UK) to Inform Feasibility of a Time and Motion Study
The observational T&M study will generate time data that are more robust than the opinion-based estimates presented.
Authors:
- Erwin De Cock (Syneos Health) & Carla Vossen (Syneos Health)
